RecruitingNCT07582783

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

Persistence to Treatment With Guselkumab in Bio-Naive Patients With Moderate-to-Severe Plaque Psoriasis: A Romanian Non-Interventional Multi-center Observational Study

Sponsor

Janssen Research & Development, LLC

Enrollment

200 participants

Start Date

May 15, 2026

Study Type

OBSERVATIONAL

Conditions

Psoriasis

Summary

This study aims to assess the proportion of participants with moderate-to-severe plaque psoriasis who continue treatment with guselkumab over a two-year period.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with psoriasis. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(19)

Mihaila G. Georgiana - Cabinet Medical Individual Dermatovenerologie

Bârlad, Romania

Qualimed SRL

Brasov, Romania

Spitalul Universitar de Urgenta Elias, Clinica de Cardiologie

Bucharest, Romania

Spitalul Clinic Colentina 1

Bucharest, Romania

Spitalul Clinic Colentina

Bucharest, Romania

Alin Nicolescu Medic Primar Dermato Venerologie

Bucharest, Romania

OptiDerm Estet

Bucharest, Romania

Spitalul Clinic Judetean de Urgenta Cluj Napoca

Cluj-Napoca, Romania

Ambulator Specialitate Sp Militar de Urgenta Dr Constantin Papilian Cluj Napoca

Cluj-Napoca, Romania

Innovative Derm SRL

Constanța, Romania

Policlinica Dr.Corbeanu

Craiova, Romania

Policlinica Top Med Buna Vestire

Craiova, Romania

Derma Lux SRL

Iași, Romania

Spitalul Clinic Judetean de Urgenta Bihor

Oradea, Romania

Derma Lux SRL 1

Reghin, Romania

Evaderm Health SRL

Slatina, Romania

Spitalul Judetean de Urgenta 'Sf.Ioan cel Nou', Sectia Oncologie

Suceava, Romania

Clinica Cabimed

Targu Mureș, Romania

Dr Tirziu Dermato Chirurgie SRL

Timișoara, Romania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07582783

Related Trials

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT0381634552 locations

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

Conditions

Summary

Eligibility

Plain Language Summary

Locations(19)

Related Trials

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nailfold Capillaroscopic Changes in Psoriasis

Anti Inflammatory Diet With Physical Therapy on Psoriasis

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Skin Microbial Ecology in Atopic Dermatitis